From: Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
Disease subtype | Sample size | Methylation (%) |
---|---|---|
B-NHLs | 99 | 68 (68.69%) |
 Diffuse large B cell lymphoma (DLBCL) | 56 | 42 (75.00%) |
 Follicular lymphoma (FL) | 6 | 4 (66.67%) |
 Mantle cell lymphoma (MCL) | 17 | 4 (23.53%) |
 Burkitt’s lymphoma (BL) | 5 | 4 (80.00%) |
 Mucosa-associated lymphoid tissue lymphoma (MALT) | 4 | 4 (100.0%) |
 Marginal zone B cell lymphoma (MZBCL) | 3 | 2 (66.67%) |
 Small lymphocytic lymphoma (SLL) | 7 | 7 (100.00%) |
 Waldenstrom’s macroglobulinemia (WM) | 1 | 1 (100.00%) |
T-NHLs | 33 | 8 (24.24%) |
 Peripheral T cell lymphoma (PTCL) | 20 | 5 (25.00%) |
 Angioimmunoblastic T cell lymphoma (AITL) | 13 | 3 (23.08%) |